'Early' and 'late' effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits

Neuropsychopharmacology

Volumn 23, Issue 5, 2000, Pages 517-527

  Martinez, Zoë A ^a   Oostwegel, Jeff ^b   Geyer, Mark A ^c   Ellison, Gaylord D ^a   Swerdlow, Neal R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apomorphine; Haloperidol; Phencyclidine; Prepulse inhibition; Schizophrenia; Sensorimotor; Startle

Indexed keywords

APOMORPHINE; DOPAMINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ANIMAL; ANTIPSYCHOTIC AGENTS, BUTYROPHENONE; APOMORPHINE; DOPAMINE AGONISTS; DRUG IMPLANTS; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; MALE; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033801898     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00147-0     Document Type: Article

References (44)

1. Amalric M., Ouagazzal A., Baunez C., Nieoullon A. Functional interactions between glutamate and dopamine in the rat striatum. Neurochem Intl. 25:1994;123-131.
2. Antelman S.M., Gershon S. Clinical application of time-dependent sensitization to antidepressant therapy. Prog Neuropsychopharm Biol Psychiat. 22:1998;65-78.
3. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;199-201.
4. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 271:1994;787-794.
5. Banerjee S.P., Zuck L.G., Yablonsky-Alter E., Lidsky T.I. Glutamate agonist activity. implications for antipsychotic drug action and schizophrenia NeuroReport. 6:1995;2500-2504.
6. Braff D., Grillon C., Geyer M. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:1992;206-215.
7. Braff D., Stone C., Callaway E., Geyer M.A., Glick I.D., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
8. Braff D.L., Swerdlow N.R., Geyer M.A. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry. 156:1999;596-602.
9. Bolino F., Di Michele V., Di Cicco L., Manna V., Danelluzzo E., Casacchia M. Sensorimotor gating and habituation evoked by electro-cutaneous stimulation in schizophrenia. Biol Psychiatry. 36:1994;670-679.
10. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry. 150:1993;1862-1867.
11. Cepeda C., Radisavljevic Z., Peacock W., Levine M.S., Buchwald N.A. Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex. Synapse. 11:1992;330-341.
12. Feifel D., Priebe K. The effects of subchronic haloperidol on intact and dizocilpine-disrupted sensorimotor gating. Psychopharmacology. 146:1999;175-179.
13. Geyer M.A., Swerdlow N.R. Measurement of startle response, prepulse inhibition, and habituation. Crawley J.N., Skolnick P. Current Protocols in Neuroscience. 1998;1-15 John Wiley & Sons, New York. unit 8.7
14. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull. 25:1990;485-498.
15. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry. 32:1992;939-943.
16. Hoffman D.C., Donovan H., Cassella J.V. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by the noncompetitive glutamate antagonist MK-801. Psychopharmacology. 111:1993;339-344.
17. Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 17:1997;92-99.
18. Jentsch J.D., Taylor J.R., Roth R.H. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology. 19:1998;105-113.
19. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. a double-blind comparison with chlorpromazine Arch Gen Psychiatry. 45:1988;789-796.
20. Keith V.A., Mansbach R.S., Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry. 30:1991;557-566.
21. Kinney G.G., Wilkinson L.O., Saywell K.L., Tricklebank M.D. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci. 19:1999;5644-5653.
22. Kumari V., Soni W., Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry. 156:1999;1046-1051.
23. Lipton J., Zeigler S., Wilkins J., Ellison G. A silicone pellet for continuous cocaine. comparison with continuous amphetamine Pharmacol Biochem Behav. 38:1991;927-930.
24. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308.
25. Mansbach R.S., Geyer M.A. Parametric determinants in pre-stimulus modification of acoustic startle. interaction with ketamine Psychopharmacology. 105:1991;162-168.
26. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
27. Martinez Z.A., Ellison G.D., Geyer M.A., Swerdlow N.R. Effects of sustained cocaine exposure on sensorimotor gating of startle in rats. Psychopharmacol. 142:1999;253-260.
28. Perry W., Braff D. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 151:1994;363-367.
29. Pietraszek M., Ossowska K. Chronic treatment with haloperidol diminshes the phencyclidine-induced sensorimotor gating deficits in rats. Arch Pharmacol. 357:1998;466-471.
30. Rigdon G.C. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacol. 102:1990;419-421.
31. Smith Y., Bennett B.D., Bolam J.P., Parent A., Sadikot A.F. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol. 344:1994;1-19.
32. Svensson A., Carlsson M.L., Carlsson A. Glutamatergic neurons projecting to the nucleus accumbens can affect motor function in opposite directions depending on the dopaminergic tone. Prog NeuroPsychopharmacol Biol Psych. 18:1994;1203-1218.
33. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther. 279:1996;1290-1299.
34. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry. 21:1986;23-33.
35. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 51:1994;139-154.
36. Swerdlow N.R., Caine S.B., Braff D.L., Geyer M.A. The neural substrates of sensorimotor gating of the startle reflex. a review of recent findings and their implications J Psychopharmacol. 6:1992;176-190.
37. Swerdlow N.R., Geyer M.A. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav. 44:1993;741-744.
38. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bull. 24:1998;285-302.
39. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P., Braff D.L., Geyer M.A. Toward understanding the biology of a complex phenotype. Rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists J. Neurosci. 20:2000;4325-4336.
40. Swerdlow N.R., Varty G.B., Geyer M.A. Discrepant findings of clozapine effects on prepulse inhibition of startle. Is it the route or the rat? Neuropsychopharmacol. 18:1997;50-56.
41. Weike A.I., Bauer U., Hamm A.O. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiat. 47:2000;61-70.
42. Varty G.B., Bakshi V.P., Geyer M.A. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacol. 20:1999;311-321.
43. Yamada S., Harano M., Annoh N., Nakamura K., Tanaka M. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats. Biological Psychiatry. 46:1999;832-838.
44. Young K.A., Brady M.D., Poche C., Hicks P.B. Changes in startle, evoked potentials, SPEM, sustained attention and negative symptoms frame a "therapeutic window" for neuroleptics. Abstr Soc Neurosci. 21:1995;170S.